APOBEC3s, members of the Apolipoprotein B mRNA-editing enzyme catalytic polypeptides (APOBECs) superfamily, exhibit overexpression across various cancer types, notably bladder47–49 and prostate cancer50,51. This evidence concerns the gene APOB and cancer.